KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $5.9 billion.

  • Eli Lilly's Other Non-Current Liabilities rose 4466.88% to $5.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.9 billion, marking a year-over-year increase of 4466.88%. This contributed to the annual value of $5.9 billion for FY2025, which is 4466.88% up from last year.
  • Eli Lilly's Other Non-Current Liabilities amounted to $5.9 billion in Q4 2025, which was up 4466.88% from $6.3 billion recorded in Q3 2025.
  • Eli Lilly's Other Non-Current Liabilities' 5-year high stood at $6.3 billion during Q3 2025, with a 5-year trough of $3.3 billion in Q2 2023.
  • Its 5-year average for Other Non-Current Liabilities is $4.2 billion, with a median of $3.9 billion in 2023.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 637.79% in 2023, then surged by 6256.65% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Other Non-Current Liabilities stood at $3.9 billion in 2021, then fell by 5.37% to $3.7 billion in 2022, then rose by 3.76% to $3.8 billion in 2023, then increased by 5.5% to $4.1 billion in 2024, then skyrocketed by 44.67% to $5.9 billion in 2025.
  • Its Other Non-Current Liabilities stands at $5.9 billion for Q4 2025, versus $6.3 billion for Q3 2025 and $5.7 billion for Q2 2025.